Welcome to follow the latest news
It is a known fact that most internationalization attempts fail due to lack of thorough preparation and adhering to the chosen strategy.
When it comes to life sciences – healthcare technology, biomedical technology and pharmaceuticals – that is an industry operating in a heavily regulated environment, any attempt to seek market growth through internationalization faces a multitude of specific considerations.
Is it a good time to start an internationalization project? Perhaps this is the first question that comes to mind? Using the opposite argument: Why would it not be?
One has to keep in mind that planning an effective internationalization with a good strategy and essential activities is a longterm project that spans from a half year to several years – depending on the target market. Half a year invested in internationalization is enough to outline a strategy at its best and to get a vague understanding of the market dynamics.
The life science industry distinguishes itself from other high-technology industries with such fundamental dimensions as applying scientific knowledge to provide technological solutions aiming to improve health care and quality of life in a highly regulated environment. At the same time, usually purchasing decisions are not made by end-consumers, but their physicians or such third party as an insurance company, for example.
Introducing Human Factors, Usability and Design Thinking
In recent years medical technology has taken a trend towards creating personalized care while seeking ways to enhance quality for patients and to lower healthcare costs. At the same time developers have to keep in mind the ease of use of the devices and gaining regulatory approval for them in the highly internationalized market.
What are we discussing?
In our series focusing on Health Tech in Chinese market inXso is organizing an interactive webinar “Health Tech China Focus” together with Tampere HealthHUB that will briefly discuss some of the key points and rather unique aspects of Chinese Health Tech initiatives and their implementation.
We are creating a new Health Tech track with Finest China.
inXso is creating a HealthTech track in collaboration with Finest China and Slush China both virtually online and offline with the goal to establish a platform bridging European and Chinese HealthTech Startup communities, BioMedTech corporates and Venture Capital investors within these fields.